Company intelligence / Profile preview

SPR Advanced Technologies

Ellicott City, Maryland, United States

Ownership: Private
Development stage: Other

Overview

SPR Advanced Technologies has developed a patented technology platform using applied physics to create electrostatic fields on surfaces that kill bacteria and viruses[3]. The technology has been funded by the Bill & Melinda Gates Foundation and received USAID support to test and deploy solutions for protecting healthcare workers from Ebola virus contamination[3].

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Bill & Melinda Gates FoundationUSAIDCenters for Disease Control and PreventionWhite House Office of Science and Technology PolicyUnited States Department of DefenseNational Emerging Infectious Diseases Laboratories (Boston University)

Beyond the preview

Go deeper on SPR Advanced Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPR Advanced Technologies.

Explore the full profile